No Detail Found!

Formulation and optimization of dimenhydrinate emulgels for topical delivery using response surface methodology

Author(s)
Qalander Khan Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Syed Nisar Hussain Shah Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Muhammad Sohail Arshad Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Faisal Usman Department of Pharmaceutics, Faculty of Pharmacy, Bahauddin Zakariya University,Multan,Pakistan
Ruqaiya Khalil Computational Chemistry Unit, Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Centre for Chemical and Biological Sciences, University of Karachi,Karachi,Pakistan
Zaheer Ul-Haq Computational Chemistry Unit, Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Centre for Chemical and Biological Sciences, University of Karachi,Karachi,Pakistan
Faheem Ahmed Siddiqui Faculty of Pharmacy, University of Central Punjab,Lahore,Pakistan
Talib Hussain Department of Pharmacy, COMSATS University Islamabad,Lahore Campus, Lahore,Pakistan
Abid Mehmood Yousaf Department of Pharmacy, COMSATS University Islamabad,Lahore Campus, Lahore,Pakistan
Syed AA Rizvi Hampton School of Pharmacy, Hampton University,Virginia,USA
Yasser Shahzad Department of Pharmacy, COMSATS University Islamabad,Lahore Campus, Lahore,Pakistan
Abstract
Development of dimenhydrinate (DMN) emulgel formulation has been described in this work with enhanced permeation for transdermal delivery of DMN for effective management of motion sickness. Various DMN emulgel formulations were prepared using central composite design in response surface methodology. Propylene glycol and olive oil were used in varying ratios as permeation enhancers along-with carbopol-934 as gelling agent. Prepared formulations were evaluated by physico-chemical properties, stability and Fourier transform infrared spectroscopy (FTIR) studies. Invitro drug release was studied using cellophane membrane. Formulation F2 showed maximum drug permeation following diffusion-based release mechanism and was used in further studies. Rat skin was used in Franz cell for ex-vivo studies to determine various permeation kinetic parameters. FTIR studies provided no evidence of chemical interaction between DMN and polymers used, whereas molecular docking revealed formation of a stable complex in the presence of aqueous environment with stable intermolecular binding and the complex was well hydrated. No evidence of skin irritation was observed in human volunteers following application of the optimized formulation. Histopathology data of the rat skin showed a decreased proliferation of the lymphocytes whereas monocytes were induced. In conclusion, combination of propylene glycol and olive oil was successfully employed for delivery of DMN through transdermal route with good permeability and prolonged release time that can be highly beneficial in treating motion sickness in unusual circumstances.
Publication Details
Page(s) 245-255
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
motion sickness, molecular docking, Response surface methodology, Emulgel, Permeation, Dimenhydrinate
References
Ahmad N,Ahmad R,Mohammed Buheazaha T,Salman Alhomoud H,Al-Nasif HA,Sarafroz M .2020 .A comparative ex vivo permeation evaluation of a novel 5-Fluorocuracil nanoemulsion-gel by topically applied in the different excised rat, goat, and cow skin. Saudi J. Biol. Sci., 27(4) : 1024-1040.
Alexander A,Khichariya A,Gupta S,Patel RJ,Giri TK,Tripathi DK,Release J. Control .2013 .Recent expansions in an emergent novel drug delivery technology: Emulgel. , 171(2) : 122-132.
Ashara K,Soniwala M,Shah K M .2017 .Emulgel: A novel drug delivery system. J. Pak. Assoc. Dermatol., 26(3) : 244-249.
Barreiro-Iglesias R,Alvarez-Lorenzo C .2002 .Thermal and FTIR characterization of films obtained from carbopol/surfactant aqueous solutions. J. Therm. Anal. Calorim, 68 : 479-488.
Belgamwar VS,Chauk DS,Mahajan HS,Jain SA,Gattani SG,Surana SJ .2009 .Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration. Pharm Dev Technol, 14(3) : 240-248.
Burger C,Shahzad Y,Brummer A,Gerber M,Du Plessis M .2017 .Traversing the skin barrier with nanoemulsions. Curr. Drug Deliv, 14(4) : 458-472.
Frett T,Green DA,Arz M,Noppe A,Petrat G,Kramer A,Kuemmel J,Tegtbur U,Jordan J .2020 .Motion sickness symptoms during jumping exercise on a shortarm centrifuge. Plos One, 15(6) : e0234361.
Gaikwad D,Jadhav N D .2019 .Development of stable emulsified formulations of Terminalia arjuna for topical application: Evaluation of antioxidant activity of final product and molecular docking study. Drug Dev, 45(11) : 1740-1750.
Ghiasi Z,Esmaeli F,Aghajani M,Ghazi-Khansari M,Faramarzi MA,Amani A .2019 .Enhancing analgesic and anti-inflammatory effects of capsaicin when loaded into olive oil nanoemulsion: An in vivo study. Int. J. Pharm., 559 : 341-347.
Golding JF .2006 .Motion sickness susceptibility. Auton Neurosci., 129(1-2) : 67-76.
Golding JF,Gresty MA .2015 .Pathophysiology and treatment of motion sickness. Curr. Opin. Neurol., 28(1) : 83-88.
Hashmat D,Shoaib MH,Ali FR,Siddiqui F FR .2020 .Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using cosolvents as penetration enhancers. Plos one, 15(2) : e0228908.
Huppert D,Grill E,Brandt T .2019 .Survey of motion sickness susceptibility in children and adolescents aged 3 months to 18 years. , 266(Suppl 1) : S65-S73.
Jadhav YG,Galgatte UC,Chaudhari PD .2013 .Estimation of dimenhydrinate in bulk and pharmaceutical dosage form: Method development and validation. Indo American J. Pharm. Res., 3 : 7001-7007.
Javed H,Shah SNH,Iqbal FM .2018 .Formulation development and evaluation of diphenhydramine nasal nano-emulgel. AAPS Pharm. Sci. Tech, 19(4) : 1730-1743.
Kashif M and Akhtar N .2019 .Dermocosmetic emulgels for anti-aging effects: Evidence from chromatographic and non-invasive biophysical techniques. Pak. J. Pharm. Sci., 32(2) : 845-852.
Khullar R,Kumar D,Seth N,Saini S N .2012 .Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm. J., 20(1) : 63-67.
Khullar R,Saini S,Seth N,Rana A .2011 .Emulgels: a surrogate approach for topically used hydrophobic drugs. Int. J. Pharm. Biol. Sci., 1 : 117-128.
Koslucher F,Munafo J,Stoffregen TA .2016 .Postural sway in men and women during nauseogenic motion of the illuminated environment. Exp. Brain Res., 234 : 2709-2720.
Leichner C,Baus RA,Jelkmann M,Plautz M,Barthelmes J,Dünnhaupt S,Bernkop-Schnürch A .2019 .In vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for nasal administration of dimenhydrinate. Drug Deliv. Transl. Res., 9 : 945-955.
Mehmood Y,Khan I,Shahzad Y,Khalid S,Asghar S,Irfan M,Asif M,Khalid I,Yousaf A,Hussain T .2019 .Facile synthesis of mesoporous silica nanoparticles using modified sol-gel method: Optimization and in vitro cytotoxicity studies. Pak. J. Pharm. Sci., 32(4) : 1805-1812.
Nejati L,Kalantari F,Bavarsad N,Saremnejad F,Moghaddam PT,Akhgari A,Part A .2018 .Investigation of using pectin and chitosan as natural excipients in pellet formulation. Int. J. Biol. Macromol, 120 : 1208-1215.
Noronha LL,Ferreira PG,Gs Lima C,Borba-Santos LP,Rozental S,De Moraes M,Silva FCD,Ferreira VF,Futuro DO .2020 .Formulation and evaluation of a novel itraconazole-clotrimazole topical emulgel for the treatment of sporotrichosis. Curr. Pharm. Des., 26(14) : 1566-1570.
Pinto F,De Barros DP,Reis C,Fonseca LP C .2019 .Optimization of nanostructured lipid carriers loaded with retinoids by central composite design. J. Mol. Liq, 293 : 111468.
Rastogi V,Kumar A,Porwal M,K Mishra A,Verma N,Verma A .2015 .Enhancement of skin permeation of glibenclamide from ethyl cellulose-polyvinyl pyrollidone based transdermal patches using olive oil and mustard oil as penetration enhancer: In vitro, exvivo and in vivo evaluation. Drug Deliv. Lett., 5(2) : 109-121.
Sanger GJ,Andrews PL .2018 .A history of drug discovery for treatment of nausea and vomiting and the implications for future research. , 9 : 913.
Shahin M,Hady SA,Hammad M,Mortada N M .2011 .Novel jojoba oil-based emulsion gel formulations for clotrimazole delivery. AAPS Pharmscitech, 12(1) : 239-247.
Sohail M,Naveed A,Abdul R,Khan HMS,Khan H HMS .2018 .An approach to enhanced stability: Formulation and characterization of Solanum lycopersicum derived lycopene based topical emulgel. Saudi Pharm J., 26(8) : 1170-1177.
Stanos SP .2007 .Topical agents for the management of musculoskeletal pain. J. Pain Symptom Manage., 33(3) : 342-355.
Usman F,Nopparat J,Javed I,Srichana T .2020 .Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models. Drug Deliv. Transl. Res., 10 : 59-69.
Windholz M,Budavari S,Stroumtsos LY,Fertig MN,Rahway NJ .1976 .An encyclopedia of chemicals and drugs. 9th Edn, : .
0

Citations

0

Downloads

11

Views